Table 3.
Matched EUS-TD group (n = 10) |
Matched PD group (n = 13) |
p value* | |
---|---|---|---|
Sex (male/female) | 7/3 | 9/4 | 0.96 |
Age (years) | 62.6 ± 12.8 | 64.3 ± 8.5 | 1.00 |
POPC diameter (mm) | 74.8 ± 20.0 | 56.0 ± 16.3 | 0.017 * |
CRP concentration (mg/dl) | 10.8 ± 6.8 | 9.3 ± 6.9 | 0.56 |
Number of postoperative days until procedure | 15.8 ± 6.8 | 10.6 ± 5.5 | 0.10 |
Pathology | |||
Pancreatic adenocarcinoma | 6 | 7 | 0.76 |
Neuroendocrine tumor | 0 | 3 | 0.10 |
Intraductal papillary mucinous neoplasm | 1 | 1 | 0.85 |
Others | 3 | 2 | 0.40 |
Data are reported as n or as mean ± SD. p values were calculated using chi-squared or Wilcoxon rank-sum tests, as appropriate.
p values < 0.05 (bold) were considered statistically significant.
CRP, C-reactive protein; EUS-TD, endoscopic ultrasound-guided transmural drainage; PD, percutaneous drainage; POPC, postoperative pancreatic collection.